{"id":"https://openalex.org/W2142004106","doi":"https://doi.org/10.1093/eurheartj/eht104","title":"Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA{middle dot}CER) trial","display_name":"Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA{middle dot}CER) trial","publication_year":2013,"publication_date":"2013-03-25","ids":{"openalex":"https://openalex.org/W2142004106","doi":"https://doi.org/10.1093/eurheartj/eht104","mag":"2142004106","pmid":"https://pubmed.ncbi.nlm.nih.gov/23530022"},"language":"en","primary_location":{"id":"doi:10.1093/eurheartj/eht104","doi":"https://doi.org/10.1093/eurheartj/eht104","is_oa":false,"landing_page_url":"https://doi.org/10.1093/eurheartj/eht104","pdf_url":null,"source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065883685","display_name":"Sergio Leonardi","orcid":"https://orcid.org/0000-0002-4800-6132","observed_orcids":["https://orcid.org/0000-0002-4800-6132","https://orcid.org/0000-0002-2447-7685"]},"institutions":[{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Leonardi","raw_affiliation_strings":["Duke Clinical Research Institute, Durham, NC, USA. s.leonardi@smatteo.pv.it","Duke Clinical Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Research Institute, Durham, NC, USA. s.leonardi@smatteo.pv.it","institution_ids":["https://openalex.org/I4405286153"]},{"raw_affiliation_string":"Duke Clinical Research Institute","institution_ids":["https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024015419","display_name":"Pierluigi Tricoci","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Tricoci","raw_affiliation_strings":["Duke Clinical Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Research Institute","institution_ids":["https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062843291","display_name":"Harvey Douglas White","orcid":"https://orcid.org/0000-0001-7712-6750","observed_orcids":["https://orcid.org/0000-0001-7712-6750"]},"institutions":[{"id":"https://openalex.org/I4210163382","display_name":"Green Lane Hospital","ror":"https://ror.org/01yssfs05","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I160648776","https://openalex.org/I4210163382"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"H. D. White","raw_affiliation_strings":["Green Lane Cardiovascular Service"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Green Lane Cardiovascular Service","institution_ids":["https://openalex.org/I4210163382"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023634772","display_name":"Paul W. Armstrong","orcid":"https://orcid.org/0000-0002-0460-3445","observed_orcids":["https://orcid.org/0000-0002-0460-3445","https://orcid.org/0000-0001-7553-1090"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"P. W. Armstrong","raw_affiliation_strings":["University of Alberta"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alberta","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Z. Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Z. Huang","raw_affiliation_strings":["Duke Clinical Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Research Institute","institution_ids":["https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063591215","display_name":"Lars C. Wallentin","orcid":"https://orcid.org/0000-0003-0378-6531","observed_orcids":["https://orcid.org/0000-0003-0378-6531"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"L. Wallentin","raw_affiliation_strings":["Uppsala Clinical Research Center Uppsala University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Uppsala Clinical Research Center Uppsala University","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033070568","display_name":"Philip E. Aylward","orcid":"https://orcid.org/0000-0002-5358-8552","observed_orcids":["https://orcid.org/0000-0002-5358-8552"]},"institutions":[{"id":"https://openalex.org/I2802931750","display_name":"Flinders Medical Centre","ror":"https://ror.org/020aczd56","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2802931750"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"P. E. Aylward","raw_affiliation_strings":["Flinders Medical Centre"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Flinders Medical Centre","institution_ids":["https://openalex.org/I2802931750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048065442","display_name":"David J. Moliterno","orcid":"https://orcid.org/0000-0002-6699-0639","observed_orcids":["https://orcid.org/0000-0002-6699-0639","https://orcid.org/0000-0002-2559-4744"]},"institutions":[{"id":"https://openalex.org/I143302722","display_name":"University of Kentucky","ror":"https://ror.org/02k3smh20","country_code":"US","type":"education","lineage":["https://openalex.org/I143302722"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. J. Moliterno","raw_affiliation_strings":["#N##TAB##TAB##TAB##TAB# Univ. of Kentucky#N##TAB##TAB##TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"#N##TAB##TAB##TAB##TAB# Univ. of Kentucky#N##TAB##TAB##TAB#","institution_ids":["https://openalex.org/I143302722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070495078","display_name":"Frans Van de Werf","orcid":"https://orcid.org/0000-0001-9479-7767","observed_orcids":["https://orcid.org/0000-0001-9479-7767"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"F. Van de Werf","raw_affiliation_strings":["*University of Leuven"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"*University of Leuven","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061001045","display_name":"E. Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Chen","raw_affiliation_strings":["Merck"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083191627","display_name":"Lu\u00eds Augusto Provid\u00eancia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802025818","display_name":"Unidade Local de Sa\u00fade de Coimbra","ror":"https://ror.org/04032fz76","country_code":"PT","type":"healthcare","lineage":["https://openalex.org/I2802025818"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"L. Providencia","raw_affiliation_strings":["Hospitais da Universidade de Coimbra "],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospitais da Universidade de Coimbra ","institution_ids":["https://openalex.org/I2802025818"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111605273","display_name":"Jan Erik Nordrehaug","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4432739","display_name":"University of Bergen","ror":"https://ror.org/03zga2b32","country_code":"NO","type":"education","lineage":["https://openalex.org/I4432739"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"J. E. Nordrehaug","raw_affiliation_strings":["University of Bergen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Bergen","institution_ids":["https://openalex.org/I4432739"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087154648","display_name":"Claes Held","orcid":"https://orcid.org/0000-0001-9402-7404","observed_orcids":["https://orcid.org/0000-0001-9402-7404"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"C. Held","raw_affiliation_strings":["Uppsala Clinical Research Center Uppsala University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Uppsala Clinical Research Center Uppsala University","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075973255","display_name":"John T. Strony","orcid":"https://orcid.org/0000-0002-8703-1146","observed_orcids":["https://orcid.org/0000-0002-8703-1146"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Strony","raw_affiliation_strings":["Merck"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111951322","display_name":"Tyrus L. Rorick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. L. Rorick","raw_affiliation_strings":["Duke Clinical Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Research Institute","institution_ids":["https://openalex.org/I4405286153"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060370891","display_name":"Robert A. Harrington","orcid":"https://orcid.org/0000-0001-5450-8676","observed_orcids":["https://orcid.org/0000-0001-5450-8676"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. A. Harrington","raw_affiliation_strings":["Stanford University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039432822","display_name":"Kenneth W. Mahaffey","orcid":"https://orcid.org/0000-0002-3791-2148","observed_orcids":["https://orcid.org/0000-0002-3791-2148"]},"institutions":[{"id":"https://openalex.org/I4405286153","display_name":"Duke Clinical Research Institute","ror":"https://ror.org/019mv4g96","country_code":"US","type":"facility","lineage":["https://openalex.org/I170897317","https://openalex.org/I4405286153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. W. Mahaffey","raw_affiliation_strings":["Duke Clinical Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Clinical Research Institute","institution_ids":["https://openalex.org/I4405286153"]}]}],"institutions":[],"countries_distinct_count":8,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5240,"currency":"EUR","value_usd":5922},"apc_paid":null,"fwci":5.4627,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.96588634,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"34","issue":"23","first_page":"1723","last_page":"1731"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.9550999999046326,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.9550999999046326,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.02710000053048134,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.011099999770522118,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vorapaxar","display_name":"vorapaxar","score":1.0},{"id":"https://openalex.org/keywords/thrombin-receptor-antagonist","display_name":"thrombin receptor antagonist","score":0.8610000014305115},{"id":"https://openalex.org/keywords/protease-activated-receptor-1","display_name":"protease-activated receptor 1","score":0.7900000214576721},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.9100000262260437},{"id":"https://openalex.org/keywords/acute-coronary-syndrome","display_name":"acute coronary syndrome","score":0.8240000009536743},{"id":"https://openalex.org/keywords/non-st-segment-elevation","display_name":"non-ST-segment elevation","score":0.7940000295639038},{"id":"https://openalex.org/keywords/type-1-myocardial-infarction","display_name":"type 1 myocardial infarction","score":0.8259999752044678},{"id":"https://openalex.org/keywords/universal-definition-of-myocardial-infarction","display_name":"universal definition of myocardial infarction","score":0.7940000295639038},{"id":"https://openalex.org/keywords/cardiac-biomarkers","display_name":"cardiac biomarkers","score":0.7829999923706055},{"id":"https://openalex.org/keywords/thienopyridines","display_name":"thienopyridines","score":0.7590000033378601},{"id":"https://openalex.org/keywords/secondary-prevention","display_name":"secondary prevention","score":0.47099998593330383}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9509377479553223},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7615426778793335},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.7325741052627563},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.7247081995010376},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.669678807258606},{"id":"https://openalex.org/C2780400711","wikidata":"https://www.wikidata.org/wiki/Q2008344","display_name":"Percutaneous coronary intervention","level":3,"score":0.5952860116958618},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5871393084526062},{"id":"https://openalex.org/C2777698277","wikidata":"https://www.wikidata.org/wiki/Q266018","display_name":"Acute coronary syndrome","level":3,"score":0.5446793437004089},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.2704886794090271},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2206856906414032}],"mesh":[{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014336","descriptor_name":"Troponin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D052279","descriptor_name":"Creatine Kinase, MB Form","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D054058","descriptor_name":"Acute Coronary Syndrome","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D054058","descriptor_name":"Acute Coronary Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D062645","descriptor_name":"Percutaneous Coronary Intervention","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1093/eurheartj/eht104","doi":"https://doi.org/10.1093/eurheartj/eht104","is_oa":false,"landing_page_url":"https://doi.org/10.1093/eurheartj/eht104","pdf_url":null,"source":{"id":"https://openalex.org/S181568219","display_name":"European Heart Journal","issn_l":"0195-668X","issn":["0195-668X","1522-9645"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Heart Journal","raw_type":"journal-article"},{"id":"pmid:23530022","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23530022","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European heart journal","raw_type":"Comparative Study"},{"id":"pmh:oai:open-archive.highwire.org:ehj:34/23/1723","doi":null,"is_oa":false,"landing_page_url":"http://eurheartj.oxfordjournals.org/cgi/content/short/34/23/1723","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W35937193","https://openalex.org/W303795847","https://openalex.org/W1553345686","https://openalex.org/W2003965226","https://openalex.org/W2020308554","https://openalex.org/W2040767703","https://openalex.org/W2061837685","https://openalex.org/W2086212270","https://openalex.org/W2087150869","https://openalex.org/W2099869131","https://openalex.org/W2123673539","https://openalex.org/W2126830306","https://openalex.org/W2134322421","https://openalex.org/W2135498889","https://openalex.org/W2138514916","https://openalex.org/W2140501627","https://openalex.org/W2142021807","https://openalex.org/W2156725039","https://openalex.org/W2169387542","https://openalex.org/W2272962241","https://openalex.org/W3170020307","https://openalex.org/W4293577771"],"related_works":["https://openalex.org/W2481987364","https://openalex.org/W7053320440","https://openalex.org/W2134322421","https://openalex.org/W1977856998","https://openalex.org/W91109828","https://openalex.org/W2174434727","https://openalex.org/W2234841805","https://openalex.org/W4247887079","https://openalex.org/W1594806861","https://openalex.org/W2413667394"],"abstract_inverted_index":{"AIMS:":[0],"The":[1,99,266],"TRA\u00b7CER":[2],"trial":[3,74],"compared":[4,243],"vorapaxar,":[5],"a":[6,87,131,256,259,273],"novel":[7],"platelet":[8],"protease-activated":[9],"receptor":[10],"(PAR)-1":[11],"antagonist,":[12],"with":[13,19,124,234,244,272],"placebo":[14],"in":[15,96,230,292],"12":[16],"944":[17],"patients":[18,231,245],"high-risk":[20],"non-ST-segment":[21],"elevation":[22],"acute":[23],"coronary":[24,115],"syndromes":[25],"(NSTE":[26],"ACS).":[27],"In":[28],"this":[29],"analysis,":[30],"we":[31],"explored":[32],"the":[33,58,73,128,152,296],"effect":[34,173,212,261],"of":[35,90,130,134,154,157,275,280,300],"vorapaxar":[36,126,202,269],"on":[37],"myocardial":[38],"infarction":[39],"(MI).":[40],"METHODS":[41],"AND":[42],"RESULTS:":[43],"A":[44],"blinded,":[45],"independent":[46],"central":[47],"endpoint":[48],"adjudication":[49],"committee":[50],"prospectively":[51],"defined":[52,218],"and":[53,151,160,224,288],"classified":[54],"MI":[55,60,118,133,183,216,301],"according":[56],"to":[57,76],"universal":[59],"definition,":[61],"including":[62,277],"peak":[63,220],"cardiac":[64,221],"marker":[65,222],"value":[66],"(creatine":[67],"kinase-MB":[68],"[CK-MB]":[69],"and/or":[70],"troponin).":[71],"Because":[72],"failed":[75],"meet":[77],"its":[78],"primary":[79],"endpoint,":[80],"these":[81],"analyses":[82],"are":[83],"considered":[84],"exploratory.":[85],"During":[86],"median":[88],"follow-up":[89],"502":[91],"days,":[92],"1580":[93],"MIs":[94,158,196],"occurred":[95],"1319":[97],"patients.":[98],"majority":[100],"(n":[101,119],"=":[102,120,149,170,192,209,263],"1025,":[103],"64.9%)":[104],"were":[105,197],"type":[106,112,136,181,293,299],"1":[107,182,294],"(spontaneous)":[108],"MI,":[109,276,295],"followed":[110],"by":[111,137,162,184,201,219],"4a":[113,195],"[percutaneous":[114],"intervention":[116],"(PCI)-related]":[117],"352;":[121],"22.3%).":[122],"Compared":[123],"placebo,":[125],"reduced":[127,180,200],"hazard":[129,153],"first":[132],"any":[135],"12%":[138],"[hazard":[139],"ratio":[140],"(HR),":[141],"0.88;":[142],"95%":[143,166,188,205,240,251],"confidence":[144],"interval":[145],"(CI),":[146],"0.79-0.98;":[147],"P":[148,169,191,208],"0.021]":[150],"total":[155,278],"number":[156,279],"(first":[159],"subsequent)":[161],"14%":[163],"(HR,":[164,186,203,238,249],"0.86;":[165],"CI,":[167,189,206,241,252],"0.77-0.97;":[168],"0.014),":[171],"an":[172],"that":[174],"was":[175,213,255,270,284,289],"sustained":[176,285],"over":[177,286],"time.":[178],"Vorapaxar":[179,211],"17%":[185],"0.83;":[187],"0.73-0.95;":[190],"0.007).":[193],"Type":[194],"not":[198,232],"significantly":[199],"0.90;":[204],"0.73-1.12;":[207],"0.35).":[210],"consistent":[214],"across":[215,225],"sizes":[217],"elevations":[223],"key":[226],"clinical":[227],"subgroups;":[228],"however,":[229],"treated":[233],"thienopyridine":[235,248],"at":[236],"baseline":[237],"0.65;":[239],"0.46-0.92)":[242],"who":[246],"received":[247],"0.91;":[250],"0.81-1.02),":[253],"there":[254],"trend":[257],"towards":[258],"higher":[260],"(Pint":[262],"0.077).":[264],"CONCLUSION:":[265],"PAR-1":[267],"antagonist":[268],"associated":[271],"reduction":[274,283],"infarctions.":[281],"This":[282],"time":[287],"mostly":[290],"evident":[291],"most":[297],"common":[298],"observed.":[302]},"counts_by_year":[{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}